|
Volumn 91, Issue 2, 2009, Pages 647-648
|
Pretreatment with gonadotropin-releasing hormone (GnRH) antagonists to prevent the flare-up effect of long-acting GnRH agonists: results of a pilot study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CETRORELIX;
ESTROGEN;
FOLLITROPIN;
GONADORELIN AGONIST;
GONADORELIN ANTAGONIST;
GONADOTROPIN;
GOSERELIN;
LONG ACTING DRUG;
LUTEINIZING HORMONE;
STEROID HORMONE;
TESTOSTERONE;
ARTICLE;
BLOOD SAMPLING;
CLINICAL TRIAL;
DISORDERS OF HORMONE METABOLISM;
DRUG CONTRAINDICATION;
ESTROGEN BLOOD LEVEL;
FEMALE;
FOLLITROPIN BLOOD LEVEL;
GONADOTROPIN BLOOD LEVEL;
GONADOTROPIN FLARE UP;
HORMONAL REGULATION;
HORMONAL THERAPY;
HUMAN;
LUTEINIZING HORMONE BLOOD LEVEL;
MALE;
NORMAL HUMAN;
PRECOCIOUS PUBERTY;
PRIORITY JOURNAL;
SEX TRANSFORMATION;
SIDE EFFECT;
SINGLE DRUG DOSE;
STEROID BLOOD LEVEL;
STEROIDOGENESIS;
TESTOSTERONE BLOOD LEVEL;
ESTRADIOL;
FEMALE;
FOLLICLE STIMULATING HORMONE, HUMAN;
GONADOTROPIN-RELEASING HORMONE;
GOSERELIN;
HORMONE ANTAGONISTS;
HUMANS;
LUTEINIZING HORMONE;
MALE;
PILOT PROJECTS;
TESTOSTERONE;
TIME FACTORS;
TRANSSEXUALISM;
TREATMENT OUTCOME;
|
EID: 59249101567
PISSN: 00150282
EISSN: None
Source Type: Journal
DOI: 10.1016/j.fertnstert.2007.11.066 Document Type: Article |
Times cited : (4)
|
References (7)
|